Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis.

Tsukahara, Yuko; Ferran, Beatriz; Minetti, Erika T; Chong, Brian S H; Gower, Adam C; Bachschmid, Markus M; Matsui, Reiko

Tsukahara, Yuko; Ferran, Beatriz; Minetti, Erika T; Chong, Brian S H; Gower, Adam C; Bachschmid, Markus M; Matsui, Reiko.

Afiliación

Tsukahara Y; Vascular Biology Section, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
Ferran B; Vascular Biology Section, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
Minetti ET; Vascular Biology Section, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
Chong BSH; Vascular Biology Section, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
Gower AC; Clinical and Translational Science Institute, Boston University School of Medicine, Boston, MA 02118, USA.
Bachschmid MM; Vascular Biology Section, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
Matsui R; Vascular Biology Section, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.

Antioxidants (Basel) ; 11(5)2022 Apr 28.

Article en En | MEDLINE | ID: mdl-35624731

Palabras clave

aging; glutaredoxin-1; immune cells; liver fibrosis; non-alcoholic steatohepatitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Antioxidants (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google